BCAP④
本日は日曜日なんですが、レポートの提出が明日朝8時に迫っているので、急遽チームミーティングを行うことに。
前日までの皆の努力もあって、レポートの内容としてはほぼ完成しており、あとはExhibit（参照）部分の完成度と、レポート全体の一貫性を高めるだけとなっていました。
とりあえず、細かいところまでチェックして、変えないといけない所を皆と共有し、手分けして作業。
＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝
[BODY]
・Page #: Personally, I prefer not to put page # on the very first page. I think page# should start from the table of contents page. We can change it very easily using Word function.
・As for chapter title2. I prefer "2. Industry Overview". "Introduction and" sounds unnecessary.・As for chapter3. please justify the right end.
・As for Chapter 4-c, "Putney has been able to remain in business by guarding its cash, while raising $6 million in additional investor financing in Q4 2009" is clear from Exhibit15???
・We defenitely need to touch Dupont Analysis and strategic positioning of benchmark companies. Can we do this??
[EXHIBIT]
・6:Revise arrow.
・7&8b: remove red underline on PetPharma.
・10: remove outline. Put an exhibit title as the above.
・11:Put an exhibit title as the above.
・I strongly suggest adding 5 force analysis chart in 3-a, which Robert made before, .
・Why don't we put a company overview slide between Ex12 and 13.
・15: difficult to understand which is putney, which is teva. Confirm font size/bold or not.
・Why don't we put "Dupont analysis" chart in 4-c and "strategic position chart" in 4-d?
＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝
２～３時間で終わると思っていましたが、帰宅したのは6時くらいでした。
でも、かなり完成度の高いレポートになったので、満足です。
前日までの皆の努力もあって、レポートの内容としてはほぼ完成しており、あとはExhibit（参照）部分の完成度と、レポート全体の一貫性を高めるだけとなっていました。
とりあえず、細かいところまでチェックして、変えないといけない所を皆と共有し、手分けして作業。
＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝
[BODY]
・Page #: Personally, I prefer not to put page # on the very first page. I think page# should start from the table of contents page. We can change it very easily using Word function.
・As for chapter title2. I prefer "2. Industry Overview". "Introduction and" sounds unnecessary.・As for chapter3. please justify the right end.
・As for Chapter 4-c, "Putney has been able to remain in business by guarding its cash, while raising $6 million in additional investor financing in Q4 2009" is clear from Exhibit15???
・We defenitely need to touch Dupont Analysis and strategic positioning of benchmark companies. Can we do this??
[EXHIBIT]
・6:Revise arrow.
・7&8b: remove red underline on PetPharma.
・10: remove outline. Put an exhibit title as the above.
・11:Put an exhibit title as the above.
・I strongly suggest adding 5 force analysis chart in 3-a, which Robert made before, .
・Why don't we put a company overview slide between Ex12 and 13.
・15: difficult to understand which is putney, which is teva. Confirm font size/bold or not.
・Why don't we put "Dupont analysis" chart in 4-c and "strategic position chart" in 4-d?
＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝＝
２～３時間で終わると思っていましたが、帰宅したのは6時くらいでした。
でも、かなり完成度の高いレポートになったので、満足です。
